March 07, 2016
Amgen has sued Sandoz in New Jersey federal court for trying to skip patent discussions related a biosimilar version of anti-infection blockbuster Neulasta, the latest legal fight over dueling interpretations of the Biologics Price Competition and Innovation Act.